Gossamer Bio (GOSS) Short term Debt: 2022-2024
Historic Short term Debt for Gossamer Bio (GOSS) over the last 1 years, with Mar 2024 value amounting to $9.6 million.
- Gossamer Bio's Short term Debt fell 17.43% to $9.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.6 million, marking a year-over-year decrease of 17.43%. This contributed to the annual value of $11.6 million for FY2023, which is negligibly% changed negligibly from last year.
- According to the latest figures from Q1 2024, Gossamer Bio's Short term Debt is $9.6 million, which was down 17.43% from $11.6 million recorded in Q4 2023.
- In the past 5 years, Gossamer Bio's Short term Debt registered a high of $11.6 million during Q4 2022, and its lowest value of $9.6 million during Q1 2024.
- Moreover, its 3-year median value for Short term Debt was $11.6 million (2023), whereas its average is $11.3 million.
- Data for Gossamer Bio's Short term Debt shows a maximum YoY dropped of 17.43% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Gossamer Bio's Short term Debt stood at $11.6 million in 2022, then remained steady at $11.6 million in 2023, then declined by 17.43% to $9.6 million in 2024.
- Its last three reported values are $9.6 million in Q1 2024, $11.6 million for Q4 2023, and $11.6 million during Q3 2023.